RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Clinical trials for RELAPSED OR REFRACTORY MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR-T therapy tested in one patient for Hard-to-Treat myeloma
Disease control TerminatedThis study tested a new CAR-T cell therapy in one person with multiple myeloma that had come back or stopped responding to other treatments. The goal was to see if the treatment was safe and could shrink the cancer. The study was stopped early, so results are very limited.
Matched conditions: RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
Experimental combo for blood cancer shows early promise but study halted
Disease control TerminatedThis study tested whether adding an experimental drug (INCB001158) to a standard therapy (daratumumab) could help people with multiple myeloma that had returned or stopped responding to treatment. The trial was open to adults who had already tried at least three prior treatments.…
Matched conditions: RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 05:05 UTC